NSB — Neuroscientific Biopharmaceuticals Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapMomentum Trap

Annual balance sheet for Neuroscientific Biopharmaceuticals, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2021 June 30th	2022 June 30th	2023 June 30th	2024 June 30th	2025 June 30th
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	14.2	7.22	4.91	4.95	7.27
Net Total Accounts Receivable
Net Total Receivables	0.049	0.121	0.043	0.054	0.098
Prepaid Expenses
Total Current Assets	14.4	7.4	5.01	5.04	7.4
Net Property, Plant And Equipment	0.028	0.017	0.009	0.006	0.001
Net Intangible Assets
Total Assets	14.8	7.74	5.29	5.44	17
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Current Liabilities	0.223	2.22	0.597	0.086	0.149
Total Long Term Debt
Total Debt
Total Liabilities	0.223	2.22	0.597	0.086	0.149
Common Stock
Retained Earnings (Accumulated Deficit)
Total Equity	14.6	5.52	4.69	5.35	16.8
Total Liabilities & Shareholders' Equity	14.8	7.74	5.29	5.44	17
Total Common Shares Outstanding